The last time we looked in on Medical Marijuana, Inc. (OTCMKTS:MJNA) was just a couple of week ago, when we were discussing the company’s partnership with NFL legend Christian Okoye, who had become a spokesperson for MJNA’s Kannaway® brand to help spread awareness on the therapeutic benefits of cannabidiol (CBD) for athletes.
Today we wanted to circle back around for MJNA to discuss another major development for its Kannaway subsidiary, as well as one for its Hempmeds subsidiary.
First Medical Marijuana, Inc. (OTCMKTS:MJNA) announced that Kannaway® has introduced “Cannabis Beauty,” a new line of anti-aging skincare products for its European customers. The collection is available to all citizens of European Union (EU) member nations as well as other countries outside of the EU.
The products in the collection are made from proprietary formulas which do not contain artificial foaming agents, sulfates, preservatives, parabens, dyes or fragrance. Each product is intended for all skin types. The brand new line includes a Burdock & Hemp Cleanser, Liquorice and Hemp Exfoliator, Green Tea Leaf & Hemp Mask, White Peony & Hemp Serum, and a Ginseng & Hemp Moisturizer. (Source: PR Newswire)
It was also reported that HempMeds® has partnered with Northshore Pharmacy to sell its Real Scientific Hemp Oil™ (RSHO™) CBD oil as a non-prescription product in Bermuda.
“Our international expansion isn’t over until we’re able to sell our cannabidiol (CBD) products in every country around the world,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We feel very fortunate to partner with this prestigious pharmacy to help expand CBD access throughout Bermuda.”
Northshore Pharmacy is owned by the husband and wife team of Jonathan and Jennie Lightbourne. The pharmacy is situated within the Northshore Medical & Aesthetics Center, which was created to help the people of Bermuda improve their physical, visual, mental and sexual health with top health service offerings and physicians.
“Our pharmacy is pleased to offer HempMeds’ CBD hemp oil products to our customers,” said Northshore Pharmacy Co-Owner and Managing Pharmacist, Jennie Lightbourne. “We’ve received a tremendous amount of positive feedback on these products and look forward to offering even more in the future.”
HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and provide high-quality CBD oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. (Source: PR Newswire)
As America’s first publicly traded cannabis company, we’ve tracked MJNA for a long time, and recently, as we pointed to above, the company’s subsidiaries have been making their presence felt in hemp/cbd markets around the globe.
The Hemp Business Journal reports an estimated $450 million of the projected $2.1 billion in CBD sales by 2020 will come from hemp-based sources. The hemp-derived CBD market was just $90 million as recently as 2015. A company like MJNA is here to stay, and appears to be doing everything in its power to continue to grow and change with the times. . We’ll stay up on any further developments with MJNA and pass them along to you!. Keep it locked on Street Register for updates, and we’ll deliver important developments on MJNA as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!
Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in MJNA stock, short or long.
This article was first published on http://streetregister.com/2018/05/15/medical-marijuana-inc-otcmktsmjna-subsidiaries-in-the-news/
Be the first to comment on "Medical Marijuana, Inc. (OTCMKTS:MJNA) Subsidiaries in the News"